Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.
Outcomes of hematopoietic cell transplantation continue to improve. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from related and unrelated donors. In June 2007, the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) convened a State of the Science Symposium (SOSS) in Ann Arbor and identified 11 high priority clinical trials for the network to pursue. This article reviews both the status of those trials and the record of achievement of the BMT CTN as it convenes another SOSS in Grapevine, Texas in February 2014.
Department of Pediatrics, University of Michigan, Ann Arbor, Michigan. Electronic address: ferrara@umich.edu.
James L M
JL
Ferrara
D016026:Bone Marrow Transplantation / Q000379:methods*; D002986:Clinical Trials as Topic; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D049674:History, 21st Century; D006801:Humans; D008297:Male; D016896:Treatment Outcome
Acute lymphocytic leukemia; Acute myeloid leukemia; Biomarkers; Cell therapy; Chronic lymphocytic leukemia; Clinical Trials Network; Clinical trials; Crohn's disease; Graft-versus-host disease; Hemaphogocytic lymphohistiocytosis; Hematopoietic cell transplantation; Quality of life; T cell lymphoma